Vallon Pharmaceuticals, Inc. Purchase Agreements
8 Contracts & Agreements
- Form of Securities Purchase Agreement (Filed With SEC on June 26, 2024)
- Form of Securities Purchase Agreement, dated as of February 1, 2024, between GRI Bio, Inc. and each purchaser named in the signature pages thereto (Filed With SEC on February 2, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on January 31, 2024)
- Asset Purchase Agreement, dated as of August 22, 2023, by and between GRI Bio, Inc. and Aardvark Therapeutics, Inc (Filed With SEC on August 23, 2023)
- Omnibus Amendment to Securities Purchase Agreements, dated February 17, 2023, by and among Vallon Pharmaceuticals, Inc., GRI Bio, Inc. and the investor party thereto (Filed With SEC on February 24, 2023)
- Amendment No. 1 to Securities Purchase Agreement dated July 25, 2022 (Filed With SEC on July 26, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on May 13, 2022)
- Amended and Restated Asset Purchase Agreement, dated as of June 22, 2017, by and among Arcturus Therapeutics, Ltd. (and its subsidiary, Arcturus Therapeutics, Inc.), Amiservice... (Filed With SEC on January 14, 2021)
